Detalles de la búsqueda
1.
Phase 2 Results Indicate Evenamide, A Selective Modulator of Glutamate Release, Is Associated With Clinically Important Long-Term Efficacy When Added to an Antipsychotic in Patients With Treatment-Resistant Schizophrenia.
Int J Neuropsychopharmacol
; 26(8): 523-528, 2023 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349110
Resultados
1 -
1
de 1
1
Próxima >
>>